Pangaea Oncology Stock Forward View - Accumulation Distribution
| PANG Stock | EUR 1.67 0.02 1.18% |
Pangaea Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Pangaea Oncology stock prices and determine the direction of Pangaea Oncology SA's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pangaea Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of Pangaea Oncology's share price is approaching 44 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Pangaea Oncology, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
Using Pangaea Oncology hype-based prediction, you can estimate the value of Pangaea Oncology SA from the perspective of Pangaea Oncology response to recently generated media hype and the effects of current headlines on its competitors.
Pangaea Oncology after-hype prediction price | EUR 1.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pangaea |
Pangaea Oncology Additional Predictive Modules
Most predictive techniques to examine Pangaea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pangaea using various technical indicators. When you analyze Pangaea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Pangaea Oncology Volatility | Backtest Pangaea Oncology | Information Ratio |
Pangaea Oncology Trading Date Momentum
| On January 29 2026 Pangaea Oncology SA was traded for 1.67 at the closing time. The highest price during the trading period was 1.67 and the lowest recorded bid was listed for 1.67 . There was no trading activity during the period 0.0. Lack of trading volume on January 29, 2026 did not cause price change. The trading delta at closing time to the current price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Pangaea Oncology to competition |
Other Forecasting Options for Pangaea Oncology
For every potential investor in Pangaea, whether a beginner or expert, Pangaea Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pangaea Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pangaea. Basic forecasting techniques help filter out the noise by identifying Pangaea Oncology's price trends.Pangaea Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pangaea Oncology stock to make a market-neutral strategy. Peer analysis of Pangaea Oncology could also be used in its relative valuation, which is a method of valuing Pangaea Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pangaea Oncology Market Strength Events
Market strength indicators help investors to evaluate how Pangaea Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pangaea Oncology shares will generate the highest return on investment. By undertsting and applying Pangaea Oncology stock market strength indicators, traders can identify Pangaea Oncology SA entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 1.67 | |||
| Day Typical Price | 1.67 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.02) | |||
| Relative Strength Index | 44.17 |
Pangaea Oncology Risk Indicators
The analysis of Pangaea Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pangaea Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pangaea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.5187 | |||
| Standard Deviation | 1.35 | |||
| Variance | 1.81 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pangaea Oncology
The number of cover stories for Pangaea Oncology depends on current market conditions and Pangaea Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pangaea Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pangaea Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Pangaea Oncology Short Properties
Pangaea Oncology's future price predictability will typically decrease when Pangaea Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pangaea Oncology SA often depends not only on the future outlook of the potential Pangaea Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pangaea Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 6.19M | |
| Average Daily Volume Last 10 Day | 697 | |
| Average Daily Volume In Three Month | 773 |
Other Information on Investing in Pangaea Stock
Pangaea Oncology financial ratios help investors to determine whether Pangaea Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pangaea with respect to the benefits of owning Pangaea Oncology security.